...
首页> 外文期刊>Frontiers in Immunology >Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells
【24h】

Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells

机译:人类关节软骨细胞通过影响直接T细胞增殖和间接抑制单核细胞分化为专业抗原呈递细胞来调节免疫反应。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Autologous chondrocyte implantation is the current gold standard cell therapy for cartilage lesions. However, in some instances, the heavily compromised health of the patient can either impair or limit the recovery of the autologous chondrocytes and a satisfactory outcome of the implant. Allogeneic human articular chondrocytes (hAC) could be a good alternative, but the possible immunological incompatibility between recipient and hAC donor should be considered. Herein, we report that allogeneic hAC inhibited T lymphocyte response to antigen-dependent and -independent proliferative stimuli. This effect was maximal when T cells and hAC were in contact and it was not relieved by the addition of exogenous lymphocyte growth factor interleukin (IL)-2. More important, hAC impaired the differentiation of peripheral blood monocytes induced with granulocyte monocyte colony-stimulating factor and IL-4 (Mo) to professional antigen-presenting cells, such as dendritic cells (DC). Indeed, a marked inhibition of the onset of the CD1a expression and an ineffective downregulation of CD14 antigens was observed in Mo–hAC co-cultures. Furthermore, compared to immature or mature DC, Mo from Mo–hAC co-cultures did not trigger an efficacious allo-response. The prostaglandin (PG) E_(2)present in the Mo–hAC co-culture conditioned media is a putative candidate of the hAC-mediated inhibition of Mo maturation. Altogether, these findings indicate that allogeneic hAC inhibit, rather than trigger, immune response and strongly suggest that an efficient chondrocyte implantation could be possible also in an allogeneic setting.
机译:自体软骨细胞植入是目前软骨损伤的金标准细胞疗法。然而,在某些情况下,严重损害患者的健康状况可能会损害或限制自体软骨细胞的恢复以及植入物的令人满意的结果。同种异体人类关节软骨细胞(hAC)可能是一个很好的选择,但应考虑受体与hAC供体之间可能的免疫学不相容性。在本文中,我们报道同种异体hAC抑制T淋巴细胞对抗原依赖性和非依赖性增殖刺激的反应。当T细胞和hAC接触时,这种作用是最大的,并且不能通过添加外源性淋巴细胞生长因子白介素(IL)-2来缓解。更重要的是,hAC损害了由粒细胞单核细胞集落刺激因子和IL-4(Mo)诱导的外周血单核细胞向树突状细胞(DC)等专业抗原呈递细胞的分化。实际上,在Mo-hAC共培养物中观察到CD1a表达的开始受到明显抑制,而CD14抗原无效下调。此外,与未成熟或成熟的DC相比,Mo-hAC共培养物中的Mo不会触发有效的同种异体反应。 Mo–hAC共培养条件培养基中存在的前列腺素(PG)E_(2)是hAC介导的Mo成熟抑制的假定候选者。总而言之,这些发现表明同种异体hAC抑制而不是触发免疫反应,并强烈暗示在同种异体环境中也可能进行有效的软骨细胞植入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号